Skip to content
PharmaInsight

Co-codamol (Codeine phosphate/paracetamol) vs Fremanezumab

National NHS prescribing compared (Prescription Cost Analysis)
Data updated March 2026

Co-codamol (Codeine phosphate/paracetamol) was dispensed 1,232,381.0× as often as Fremanezumab in March 2026 — 1,232,381 items versus 1 in England.

1,232,381items

Co-codamol (Codeine phosphate/paracetamol) · March 2026

NHSBSA Prescription Cost Analysis

1items

Fremanezumab · March 2026

NHSBSA Prescription Cost Analysis

Figure 1. Co-codamol (Codeine phosphate/paracetamol) versus Fremanezumab: national items dispensed by month

▬ Co-codamol (Codeine phosphate/paracetamol)   ·   ╌ Fremanezumab

Fremanezumab 1,232,381

Source: NHSBSA Prescription Cost Analysis, to March 2026

Co-codamol (Codeine phosphate/paracetamol) versus Fremanezumab, March 2026
Measure Co-codamol (Codeine phosphate/paracetamol) Fremanezumab
Items, March 2026 1,232,381 1
Items, last 12 months 14,910,786 16
Net ingredient cost, March 2026 £7,059,673 £450

See the full profile for Co-codamol (Codeine phosphate/paracetamol) or Fremanezumab.